-+ 0.00%
-+ 0.00%
-+ 0.00%

BLOSSOMHILL THERAPEUTICS INC : LEERINK PARTNERS RAISES TARGET PRICE TO $40 FROM $36

Reuters·09/21/2026 13:55:01